Substantive final action
HB3834
House: THIRD READING
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Passed House March 11, 2026⭐ Substantive final action
Yea (68)
Nay (23)
Absent (8)
Republicans (81)
69% yea among members casting a yea or nay vote (51–23).
Democrats (18)
100% yea among members casting a yea or nay vote (17–0).